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Abstract
Background: SEDLIN, a 140 amino acid subunit of the Transport Protein Particle (TRAPP) complex, is ubiquitously expressed
and interacts with the transcription factors c-myc promoter-binding protein 1 (MBP1), pituitary homeobox 1 (PITX1) and
steroidogenic factor 1 (SF1). SEDLIN mutations cause X-linked spondyloepiphyseal dysplasia tarda (SEDT).
Methodology/Principal Findings: We investigated the effects of 4 missense (Asp47Tyr, Ser73Leu, Phe83Ser and Val130Asp)
and the most C-terminal nonsense (Gln131Stop) SEDT-associated mutations on interactions with MBP1, PITX1 and SF1 by
expression in COS7 cells. Wild-type SEDLIN was present in the cytoplasm and nucleus and interacted with MBP1, PITX1 and
SF1; the SEDLIN mutations did not alter these subcellular localizations or the interactions. However, SEDLIN was found to
homodimerize, and the formation of dimers between wild-type and mutant SEDLIN would mask a loss in these interactions.
A mammalian SEDLIN null cell-line is not available, and the interactions between SEDLIN and the transcription factors were
therefore investigated in yeast, which does not endogenously express SEDLIN. This revealed that all the SEDT mutations,
except Asp47Tyr, lead to a loss of interaction with MBP1, PITX1 and SF1. Three-dimensional modelling studies of SEDLIN
revealed that Asp47 resides on the surface whereas all the other mutant residues lie within the hydrophobic core of the
protein, and hence are likely to affect the correct folding of SEDLIN and thereby disrupt protein-protein interactions.
Conclusions/Significance: Our studies demonstrate that SEDLIN is present in the nucleus, forms homodimers and that
SEDT-associated mutations cause a loss of interaction with the transcription factors MBP1, PITX1 and SF1.
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Introduction
SEDLIN, which is one of the subunits of the Transport Protein
Particle (TRAPP) complex, is involved in the targeting and fusion
of endoplasmic reticulum (ER)-derived transport vesicles to the
Golgi acceptor compartment [1]. SEDLIN, which is encoded by
the spondyloepiphyseal dysplasia late (SEDL) gene (Figure 1) is a
highly conserved 140 amino acid protein with a .95% identity
amongst vertebrate orthologues and a .30% identity to the yeast
Trs20p [2]. The crystal structure of mouse Sedlin shows it to have
a single domain structure (Figure 2) that contains 20 solvent-
accessible apolar residues [2]. Four of these apolar residues
constitute the hydrophobic pocket (Pro16) and the hydrophobic
groove (Phe40, Leu48 and Phe67), both of which may act as
protein-binding sites [2]. Indeed, SEDLIN has been reported to
interact with proteins that are not part of the TRAPP complex,
but are either transcription factors, such as the c-myc promoter-
binding protein 1 (MBP1), pituitary homeobox 1 (PITX1) and
steroidogenic factor 1 (SF1) [3,4], or the intracellular chloride
channels, CLIC1 and CLIC2 [5]. Interestingly, SEDLIN has been
reported to localize to the perinuclear structures [6], although the
reported interactions with the transcription factors MBP1, PITX1
and SF1, would also suggest a role for SEDLIN in the nucleus.
Mutations of SEDLIN have been reported in patients with
spondyloepiphyseal dysplasia tarda (SEDT), an X-linked osteo-
chondrodysplasia that is characterised by short stature, a
disproportionate short trunk, barrel-shaped chest, narrowing of
the intervertebral disc spaces, platyspondyly, a shortened femoral
neck, and early onset secondary osteoarthritis which may require
hip replacement before the age of 40 years [7]. The forty-four
disease-causing SEDL mutations, which had been reported at the
commencement of these studies, consisted of 40 that resulted in
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premature truncations and 4 that were missense mutations
(Asp47Tyr, Ser73Leu, Phe83Ser and Val130Asp) (Figure 1).
However, the functional consequences of these SEDL mutations
at the cellular level remain unidentified and we hypothesised that
these may involve a loss of interactions with MBP1, PITX1 and
SF1, particularly as PITX1 and MBP1, which is also referred to as
enolase1, have been reported to have roles in endochondral
ossification and maintenance of adult bone [8,9]. Moreover,
PITX1 expression has been reported to be significantly reduced in
osteoarthritic cartilage [9], and citrullinated enolase1, which is a
known rheumatoid arthritis autoantigen, is expressed at high levels
in rheumatoid joints [8]. We therefore undertook studies that
aimed to explore the nuclear expression of SEDLIN, which would
be consistent with its interactions with the transcription factors
MBP1, PITX1 and SF1, and to determine the functional
consequences of disease-associated SEDLIN mutations on the
subcellular localization and interactions with PITX1, MBP1 and
SF1. We focused on the 4 SEDT-associated missense mutations
(Figure 1) as these were predicted to yield a full-length protein and
were not likely to affect the tertiary structure of SEDLIN
substantially, as well as the most C-terminal nonsense
(Gln131Stop) mutation, which if translated, is predicted to result
in the loss of the last ten amino acids.
Results
Subcellular Localization of SEDLIN
SEDLIN has been postulated to play a role in ER-Golgi
vesicular transport and has been reported to localize to perinuclear
structures [6]. However, its interaction with the transcription
factors MBP1, PITX1 and SF1 suggested a possible nuclear
localization. We explored this possibility by confocal immunoflu-
orescence studies of COS7 cells that were transiently transfected
with cMyc- or HA-tagged constructs of wild-type (WT) SEDLIN,
mutant SEDLIN, wild-type MBP1, PITX1 or SF1. We specifically
chose to generate the tagged constructs using cMyc- and HA-tags
as these are small proteins (,1.5 kDa) [10,11] unlike a green
fluorescence protein (GFP)-tag (,27 kDa) [12], and hence less
likely to affect the biochemical and biophysical properties of
SEDLIN, which is itself only 16 kDa in size. Wild-type cMyc-
SEDLIN expression was observed in the nucleus and cytoplasm
(Figure 3A), and the SEDT-associated mutations (Asp47Tyr,
Ser73Leu, Phe83Ser, Val130Asp and Gln131Stop) were found to
have a similar cytoplasmic and nuclear localization, and not to
affect this subcellular localization (data not shown). MBP1, PITX1
and SF1 were also expressed in the nucleus and cytoplasm, but
PITX1 and SF1 co-localized with SEDLIN in the nucleus only,
whereas MBP1 co-localized with SEDLIN in the nucleus and
cytoplasm (Figure 3B). These results were confirmed by Western
blot analysis of subcellular fractions, which demonstrated the
presence of wild-type and mutant SEDLINs in both the
cytoplasmic and nuclear fractions (Figure 3C). This presence of
wild-type and mutant SEDLINs with the transcription factors
MBP1, PITX1 and SF1 in the nucleus and cytoplasm (Figures 3B
and C) suggested that the effects of the SEDT-associated
mutations on the interactions between SEDLIN and these
transcription factors may occur in either compartment, and these
effects were therefore assessed for in total cell lysates.
Interaction of wild-type and mutant SEDLINs with MBP1,
PITX1 and SF1 is masked by formation of SEDLIN dimers
in mammalian cells
Interactions in mammalian cells between wild-type (WT) and
mutant (Asp47Tyr, Ser73Leu, Phe83Ser, Val130Asp and
Gln131Stop) SEDLINs and the transcription factors MBP1,
PITX1 and SF1 were investigated by co-transfecting COS7 cells
with full-length wild-type SEDLIN or mutant SEDLIN constructs
that were tagged with an HA epitope, and full-length wild-type
MBP1, PITX1 and SF1 constructs that were tagged with a cMyc
Figure 1. Schematic representation of genomic organization of the SEDL gene, illustrating the 44 identified mutations. The human
SEDL gene consists of six exons that span approximately 22 Kb of genomic DNA and encode a 140 amino acid protein. The 420bp coding region
(open boxes) is organised into 4 exons (exon 3 to exon 6) and 3 introns (indicated by a line, not to scale). Non-coding exons (filled boxes) consist of
exons 1 and 2, the 59 portion of exon 3 and the 39 portion of exon 6. The sizes of the exons, and the translation Start (ATG) and Stop (TGA) codons in
exon 3 and 6, respectively, are indicated. The locations of the 44 mutations are indicated, and these consist of: 7 nonsense, 4 missense, 10 splice site,
1 insertion, 15 intraexonic deletions, and 7 deletions that encompassed introns and exons. The four missense mutations (Asp47Tyr, Ser73Leu,
Phe83Ser and Val130Asp) and one nonsense mutation (Gln131Stop) were selected for further functional studies (Figures 3, 4, 6 and 7).
doi:10.1371/journal.pone.0010646.g001
Effects of SEDLIN Mutations
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epitope. The cMyc empty vector was used as a negative control.
When wild-type or mutant HA-SEDLIN was immunoprecipitated
with anti-HA antibody, the immunoreactive bands of cMyc-
MBP1, cMyc-PITX1 and cMyc-SF1 (Figures 4A–C) were
detected in the immunoprecipitate. Wild-type and mutant HA-
SEDLINs were reciprocally co-immunoprecipitated with cMyc-
MBP1, cMyc-PITX1 and cMyc-SF1 using anti-cMyc antibody
(Figures 4A–C). The co-immunoprecipitation of MBP1, PITX1
and SF1 with wild-type and mutant SEDLIN was specific as the
HA tag alone did not co-immunoprecipitate these proteins
(Figure 4D). These results demonstrate that wild-type SEDLIN
interacts with MBP1, PITX1 and SF1; however, they also suggest
that the SEDT-associated mutations do not affect the interactions
between the mutant SEDLINs and the transcription factors
MBP1, PITX1 or SF1 (Figures 4A–C). This was a surprising
result, and the apparent lack of any effect on these interactions by
the SEDT-associated mutations was further explored. One
possibility for not observing any effects of the mutant SEDLINs
on the interactions with the transcription factors in the transfected
cells is that SEDLIN forms dimers (Figure 5A). Thus, the
formation of dimers between the endogenously expressed wild-
type SEDLIN and the transfected mutant SEDLIN would mask
the loss of any interaction between the mutant SEDLIN and the
transcription factor, as the endogenously expressed wild-type
SEDLIN would bind to the transcription factor. COS7 cells were
found to endogenously express wild-type SEDLIN, consistent with
this possibility (Figure 5B) of homodimerization, which was
investigated further by non-denaturing gel electrophoresis and
co-immunoprecipitation (Figure 6). Western blot analysis of
nuclear and cytoplasmic fractions obtained from COS7 cells
transfected with wild-type cMyc-SEDLIN, and resolved by non-
denaturing gel electrophoresis, revealed the presence of a 36 kDa
band which is consistent with the formation of SEDLIN dimers in
both compartments (Figure 6A). In addition, co-immunoprecipi-
tation studies using Western blot analysis of lysates of COS7 cells
that were co-transfected with wild-type cMyc-SEDLIN and wild-
type or mutant HA-SEDLINs, demonstrated that wild-type cMyc-
SEDLIN was able to co-immunoprecipitate wild-type and mutant
HA-SEDLINs (Figure 6B), thereby revealing that mutant SEDLIN
interacts with wild-type SEDLIN. Thus, SEDLIN forms homodi-
mers, including dimers between wild-type and mutant SEDLINs,
as postulated by our proposed model (Figure 5A) to explain the
apparent lack of observable effects of SEDLIN mutations on the
interactions with the transcription factors MBP1, PITX1 and SF1.
However, it is important to note that affected SEDT males are
hemizygous, and their cells would express only the mutant
SEDLIN, and that the situation of homodimer formation between
wild-type and mutant SEDLIN would only occur in carrier
females as the SEDL gene escapes X-chromosome inactivation
[13]. This indicates that to study the effects of the transfected
SEDLIN mutants on interactions with MBP1, PITX1 and SF1,
and simulate the situation in the hemizygous affected SEDT
males, one requires a cell line that does not express endogenous
wild-type SEDLIN. An assessment of 3 other mammalian cell lines
(COS1, HEK293 and HK2) revealed all of them to express
SEDLIN (Figure 5B), and as SEDLIN-null cell lines are not
available from SEDT patients or a mouse model, we further
explored the effects of mutant SEDLINs on the interaction with
the transcription factors MBP1, PITX1 and SF1, in yeast cells.
SEDLIN interactions with transcription factors MBP1,
PITX1 and SF1 in yeast cells
Yeast cells express Trs20p, which is a SEDLIN homologue that
is located in the ER and Golgi membranes [1,14]. Trs20p has
,40% identity at the amino acid level to mammalian SEDLIN
[2], thereby reducing the likelihood that it may form dimers with
the transfected human SEDLIN and interfere with the interaction
between mutant SEDLINs and the transcription factors. We
therefore used a yeast two-hybrid assay to assess for interactions
between wild-type and mutant SEDLINs and the transcription
factors MBP1, PITX1 and SF1. The results demonstrated that
wild-type SEDLIN interacted with wild-type SEDLIN (Figure 7A),
consistent with the findings of dimer formation in mammalian
COS7 cells (Figure 6A). Wild-type SEDLIN was also found to
interact with each of the SEDLIN mutants (Figure 7A), and hence
consistent with the results of the co-immunoprecipitation studies in
mammalian COS7 (Figure 6B). In addition, wild-type SEDLIN
Figure 2. Three-dimensional model of SEDLIN showing loca-
tions of residues involved in the mutations studied. The model is
based on a published model of mouse Sedlin [2]. (A) A ribbon model of
Sedlin showing the alpha helices in red, beta strands in blue and the
residues involved in the missense mutations (Asp47Tyr, Ser73Leu,
Phe83Ser, and Val130Asp) in yellow. The bold line indicates the 10 C-
terminal amino acids that would be deleted by the nonsense SEDLIN
mutation (Gln131Stop) shown in yellow. The dashed circle indicates the
hydrophobic core of Sedlin. The Ser119 and Ser124 residues that were
predicted to be phosphorylation sites (NetPhos2.0, MotifScan and ELM
databases) are indicated in green. (B) An ,45u rotated view of the
ribbon model of Sedlin showing the SEDT-associated mutated residues
Asp47 and Ser73 (yellow), in SEDT, which together with the residues
Tyr60, Thr63, His67 and Gln91 (light blue) aid in forming the
hydrophobic groove (indicated by dotted bar line). The alpha helices
are shown in red, beta strands in blue, and the linker region in grey.
doi:10.1371/journal.pone.0010646.g002
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Figure 3. Subcellular co-localization of wild-type and mutant SEDLINs, MBP1, PITX1 and SF1. (A) COS7 cells were transfected with wild-
type or mutant (Asp47Tyr, Ser73Leu, Phe83Ser, Val130Asp and Gln131Stop) cMyc-SEDLIN constructs and visualised by immunofluorescence. The
wild-type cMyc-SEDLIN (green) and mutant forms (data not shown) were found to localize to the nucleus and cytoplasm. DAPI, which stains nuclei
(shown as red), colocalized with SEDLIN (yellow in merged image). (B) Wild-type or mutant HA-SEDLINs (red) were co-transfected with cMyc-MBP1,
cMyc-PITX1 or cMyc-SF1 constructs and visualized by immunofluorescence (green). Wild-type SEDLIN and mutant SEDLINs (data not shown) co-
localized (yellow) to the nucleus with the three transcription factors and to punctate structures within the cytoplasm with MBP1. (C) Western blot
analysis of subcellular fractions (N - nuclear, C–cytoplasmic) from COS7 cells transiently co-transfected with wild-type (WT) or one of the 5 mutant HA-
SEDLIN constructs, and cMyc-MBP1, cMyc-PITX1 or cMyc-SF1 constructs. Use of anti-HA antibody detected the expected 18 kDa wild-type and
mutant SEDLIN proteins, and anti-cMyc antibody detected the expected 36 kDa, 36 kDa and 54 kDa MBP1, PITX1 and SF1 proteins, respectively,
Effects of SEDLIN Mutations
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was demonstrated to interact with MBP1, PITX1 and SF1
(Figure 7B), yielding results that were similar to those obtained
from the mammalian COS7 cells (Figure 4). However, the
SEDLIN missense mutations Ser73Leu, Phe83Ser, Val130Asp
and the nonsense mutation Gln131Stop lead to a loss of
interaction with MBP1, PITX1 and SF1 (Figure 7B), although
the Asp47Tyr mutation, which involves a highly conserved residue
did not lead to a loss of interaction with any of these transcription
factors. Co-expression of these proteins was confirmed by Western
blot analysis of yeast protein extracts from each clone (data not
shown). These results from a yeast two-hybrid assay demonstrate
that 3 of the SEDT-associated missense mutations (Ser73Leu,
Phe83Ser, Val130Asp) and the most C-terminal nonsense
mutation (Gln131Stop) result in a loss of direct interaction with
the transcription factors MBP1, PITX1 and SF1. In addition,
these results confirm the direct interactions that lead to the
formation of dimers between human wild-type SEDLIN and
mutant SEDLINs.
Structural effects of SEDLIN mutants
An analysis of the three-dimensional structure of SEDLIN revealed
that the SEDLIN mutants (Ser73Leu, Phe83Ser, Val130Asp and
Gln131Stop) that lead to a loss of interaction with the MBP1, PITX1
and SF1, are buried within the hydrophobic core domain of SEDLIN
Figure 4. Interactions between SEDLIN, and MBP1, PITX1 and SF1. Co-immunoprecipitation studies using COS7 cells demonstrated interactions
between wild-type SEDLIN, mutant SEDLINs (Asp47Tyr, Ser73Leu, Phe83Ser, Val130Asp and Gln131Stop, only data from Ser73Leu SEDLIN shown) and
MBP1, PITX1 and SF1. (A) cMyc-MBP1 co-transfected with wild-type or mutant HA-SEDLIN; (B) cMyc-PITX1 co-transfected with wild-type or mutant HA-
SEDLIN; (C) cMyc-SF1 co-transfected with wild-type or mutant HA-SEDLIN; and (D) empty cMyc vector co-transfected with HA-SEDLIN or empty HA vector
co-transfected with cMyc-MBP1, cMyc-PITX1 or cMyc-SF1 constructs. Lysates were incubated with either anti-cMyc polyclonal antibody (M) or anti-HA
polyclonal antibody (H), or without any antibody as a negative control (2) and immunoprecipitated with Protein G-Sepharose beads. Protein complexes
were eluted and resolved on SDS-PAGE followed by Western blot analysis using an antibody to the cMyc epitope for MBP1, PITX1 and SF1, and to the HA
epitope for SEDLIN. Five percent of the lysate (input (I)) that was used for the immunoprecipitation was electrophoresed in parallel with the
immunoprecipitated lysates. Wild-type SEDLIN co-immunoprecipitated MBP1, PITX1 and SF1 and the SEDLIN mutations (Asp47Tyr, Ser73Leu, Phe83Ser,
Val130Asp and Gln131Stop) did not disrupt these interactions (representative data for mutant Ser73Leu SEDLIN shown).
doi:10.1371/journal.pone.0010646.g004
which were seen in the nuclear and cytoplasmic fractions, thereby confirming the immunofluorescence results. Western blots with anti-a-Tubulin and
anti-Lamin A/C antibodies confirmed that the nuclear and cytoplasmic fractions were free from detectable amounts of cytoplasmic and nuclear
fractions, respectively. Untransfected (UT) cells-not transfected with HA-SEDLIN. Wild-type and mutant SEDLINs were found in the nuclear and
cytoplasmic fractions, and the SEDLIN mutants did not lead to an altered subcellular localization of MBP1, PITX1 and SF1. Scale bars, 10 mm.
doi:10.1371/journal.pone.0010646.g003
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and these may affect the structural integrity of SEDLIN, as well as the
surfaces that are involved in interactions with these proteins (Figure 2).
For example, mutation of polar Ser73 to Leu73 would result in the
loss of hydrogen bonding with the side chain of Tyr60 andHis87, and
with the backbone nitrogen atoms of Thr63 and Gln91 and the
disruption of a hydrophobic groove between a1 and b3 [2]. Similarly,
the Phe83 and Val130 residues are in the hydrophobic region within
the interior of the protein, and mutations of these apolar residues to
polar residues (serine and aspartic acid, respectively) will likely disrupt
the interactions within the hydrophobic core (Figure 2), leading to a
misfolding of SEDLIN that will disrupt protein-protein interactions.
The loss of interactions between the truncated Gln131Stop mutant
protein, which comprises .90% of the full-length 140 amino acid
SEDLIN protein, and MBP1, PITX1 and SF1, also indicate that
protein misfolding rather than a lack of protein is the most likely
explanation for a loss of interaction with the transcription factors. The
Asp47Tyr SEDLINmutation did not lead to a loss of interaction with
MBP1, PITX1 and SF1. This mutation of the Asp47 residue, which is
exposed on the surface of SEDLIN, is unlikely to cause aberrant
protein folding and this is a likely explanation for a lack of disruption
in the interactions with MBP1, PITX1 and SF1.
Discussion
Our results show that SEDLIN forms homodimers (Figures 6
and 7), is localized to the cytoplasm and nucleus (Figure 3), and
that wild-type SEDLIN co-localizes and interacts with the
transcription factors MBP1, PITX1 and SF1 (Figures 3, 4 and
7). In addition, our results show that SEDT-associated SEDLIN
mutations do not result in abnormalities of subcellular localization
(Figure 3), but those involving residues within the hydrophobic
core (Figure 2) do lead to a loss of interactions with the
transcription factors MBP1, PITX1 and SF1 (Figure 7). The
relevance and further insights provided by these findings may help
to elucidate the role of SEDLIN in cellular functions.
The dimerization of SEDLIN and its nuclear localization points
to additional roles for mammalian SEDLIN, which with its yeast
orthologue Trs20p, have previously been reported to be present as
monomers in the TRAPP complex, where SEDLIN is involved in
tethering vesicles [1]. However, the formation of SEDLIN dimers
(Figures 6 and 7) and their nuclear localization (Figures 3 and 6)
together with the interactions with MBP1, PITX1 and SF1
(Figures 4 and 7) indicate a role in modulating transcription and
the situation may be analogous to that observed with the c-Jun N-
terminal kinase (JNK)-interacting protein 1 (JIP-1). The mono-
meric form of JIP-1 is a cytoplasmic scaffold protein that is
essential for the organization of the JNK signalling pathway, while
the dimeric form is predominantly located in the nucleus, where it
likely mediates transcription control of pathways involved in
prevention of neuronal death [15]. The dimerization of JIP-1
involves post-translation modification and is dependent on
phosphorylation [15], and it is interesting to note that SEDLIN
has predicted phosphorylation sites at Ser119 and Ser124
(NetPhos2.0, MotifScan and ELM databases) (Figure 2A). The
mechanisms that transport SEDLIN into the nucleus remain to be
defined, as SEDLIN does not have a nuclear localization signal
(NLS). It seems likely that SEDLIN may be co-transported with
the interacting proteins that contain NLSs, thereby enabling it to
Figure 5. Schematic model for SEDLIN homodimerization and SEDL expression in common cell lines. (A) Homodimers that have formed
between the transfected mutant cMyc-SEDLIN and the endogenously expressed wild-type SEDLIN could mask the loss of interaction between mutant
SEDLINs and MBP1, PITX1 and SF1 in transfected COS7 cells. Thus, although the mutant SEDLIN may not directly interact with MBP1, PITX1 or SF1, the
endogenously expressed SEDLIN will interact with these transcription factors, and hence the resultant homodimers will overall be seen to interact
with the transcription factors. This proposed model provides an explanation for the observed results in the transfected cells. However, it is important
to note that this situation of homodimers consisting of a wild-type and mutant SEDLIN would not normally occur in males affected with SEDT, as they
are hemizygous and their cells would normally express the mutant SEDLIN; however this situation would occur in SEDT heterozygous carrier females
because the SEDL gene escapes X-chromosome inactivation [13] and hence their cells would express both the wild-type and mutant SEDLINs. (B) RT-
PCR analysis was used to detect the endogenous expression of SEDL in COS7, COS1, HEK293 and HK2 kidney cells, as a reliable SEDLIN antibody is not
available. Detection of Calmodulin expression was used as an internal control for RNA quality and concentration; (+) with RTase, (2) without RTase.
doi:10.1371/journal.pone.0010646.g005
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enter the nucleus [16]. Within the nucleus SEDLIN, given its
interaction with the transcription factors MBP1, PITX1 and SF1,
may act as either a co-repressor or co-activator of gene
transcription. For example, SEDLIN acts as a repressor molecule
by binding to PITX1 and SF1 and inhibiting transactivation [4],
as well as an activator by binding to repressor molecules such as
MBP1 that facilitate gene transcription [3]. The roles of these
interactions between SEDLIN and MBP1, PITX1 and SF1 in
skeletal biology remain to be elucidated. However, in vitro studies
have shown that SEDLIN inhibits MBP1 mediated repression of c-
myc transcription [3], and MBP1 has been reported to be
associated with two different cellular processes during endochon-
dral ossification; cell proliferation in the proliferative and upper
hypertrophic layers, and apoptosis in the lower hypertrophic layer
of the growth plate [17]. Thus, one possibility may be that the
mutant SEDLINs that are associated with SEDT and lead to a loss
of interaction with MBP1 may disrupt the tight control between
proliferation and apoptosis in endochondral ossification. In
addition, SEDLIN has been reported to inhibit the PITX1 and
SF1 mediated transactivation of the b-subunit of the luteinizing
hormone [4], and the effects of the loss of interaction, due to the
SEDLIN mutations, between SEDLIN and PITX1 and SF1 on
the pituitary-gonadal response and the delayed puberty observed
in some boys affected with SEDT [18] remain to be defined.
The Asp47Tyr SEDT-causing mutation, unlike the Ser73Leu,
Phe83Ser, Val130Asp and Gln131Stop mutants, did not result in
loss of interaction with MBP1, PITX1 and SF1 (Figure 7).
However, the Asp47 residue, which is conserved through to yeast,
has an important functional role, as in a yeast complementation
study, the mutant SEDLIN, Asp47Tyr, failed to rescue the lethal
trs20pD phenotype [1,2,19]. The basis of these major consequences
of the Asp47Tyr mutation remains to be defined. However, it is
interesting to note that the Asp47Tyr mutation involves a residue
on the surface of SEDLIN (Figure 2) that could possibly lead to
loss of postulated or known interactions with other proteins, such
as: the soluble N-ethylmaleimide-sensitive factor attachment
(SNARE) proteins [1], which are also involved in the vesicle
transport pathway [1]; or the intracellular chloride channels
CLIC1 and CLIC2 [5], respectively.
In summary, our results show that SEDLIN is a nuclear and
cytoplasmic protein that forms homodimers. Moreover, 3 of the
SEDLIN missense mutations (Ser73Leu, Phe83Ser and Va-
Figure 6. SEDLIN forms homodimers. (A) Western blot analysis, using a monoclonal anti-cMyc antibody, of cell lysates obtained from COS7 cells
transfected with cMyc-SEDLIN or cMyc vector alone, and resolved by continuous non-denaturing PAGE; lanes 1-3, cytoplasmic fractions; lanes 4–6, nuclear
fractions; lane 1 and 4, transfected with cMyc-SEDLIN wild-type (WT) construct; lanes 2 and 5, transfected with cMyc vector alone; and lanes 3 and 6,
untransfected (UT) cells. cMyc-SEDLIN, an 18 kDa protein (Figures 3 and 4) appeared as a 36 kDa protein on non-denaturing PAGE of cytoplasmic and
nuclear fractions obtained from COS7 cells transfected with the cMyc-SEDLIN wild-type (WT) construct, consistent with homodimerization of SEDLIN
protein. (B) Co-immunoprecipitation of wild-type (WT) cMyc-SEDLIN with wild-type or mutant HA-SEDLINs (data for mutant Ser73Leu, shown). Anti-cMyc
antibody co-immunoprecipitated wild-type HA-SEDLIN in the presence of cMyc-SEDLIN (lane M) and anti-HA antibody co-immunoprecipitated cMyc-
SEDLIN in the presence of HA-SEDLIN (lane H); in the absence of the anti-cMyc or anti-HA antibodies SEDLIN was not immunoprecipitated (lane -). Five
percent of the lysate (input (I)) that was used for the immunoprecipitation was electrophoresed in parallel with immunoprecipitated lysates. Similar results
were observed for the other SEDLIN mutants (Asp47Tyr, Phe83Ser, Val130Asp and Gln131Stop) (data not shown).
doi:10.1371/journal.pone.0010646.g006
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l130Asp) and 1 nonsense mutation (Gln131Stop) located within
the hydrophobic core and associated with SEDT in patients lead
to a loss of interactions with the transcription factors MBP1,
PITX1 and SF1.
Materials and Methods
Generation of SEDLIN, MBP1, PITX1 and SF1 constructs
Total RNA was isolated from HEK293 cells using Trizol
(Invitrogen Corporation) and 2 mg was utilised to generate first
strand cDNAs by reverse transcriptase (RT)-PCR using random
hexamers and 200 U/ml Avian Myeloblastosis virus (AMV)
RTase (Transgenomic Inc.) at 42uC for 45 min. The coding
regions of SEDL, MBP1 and PITX1 were amplified using gene-
specific primers (sequences available on request). These RT-PCR
products were cloned in-frame into the expression vector pGEMT
(Promega). The pGEMT-wild-type SEDLIN construct was used to
generate mutant SEDLIN constructs that harboured the four
missense mutations (Asp47Tyr, Ser73Leu, Phe83Ser and Va-
l130Asp) and the C-terminal nonsense mutation Gln131Stop
(Figure 1) [20–22] using site-directed mutagenesis (Quik-
ChangeHXL, Stratagene), as previously described [23]. The SF1
cDNA in the pCIneo vector [24] was used to subclone SF1 into
pGEMT. The wild-type and mutant SEDLINs, MBP1, PITX1
and SF1 were digested from the pGEMT vector, subcloned in-
frame into pCMV-cMyc, pCMV-HA, pGBKT7 and pGADT7
vectors (Clontech) and DNA sequences verified using methods
previously described [23].
Figure 7. Interactions between SEDLIN, MBP1, PITX1 and SF1 using the yeast two-hybrid assay. Yeast cells, which do not have
endogenous expression of SEDLIN, were used to investigate the interactions of wild-type or mutant SEDLIN (Asp47Tyr, Ser73Leu, Phe83Ser,
Val130Asp and Gln131Stop) with wild-type SEDLIN, MBP1, PITX1 or SF1. The yeast reporter strain AH109 was used, and p53 and the SV40 large T
antigen, which are known to interact [27], were used as a positive control. The yeasts were transformed with the vectors containing: (A) wild-type
SEDLIN in pGADT7-AD (AD-WT) and either wild-type or mutant SEDLINs in pGBKT7-BD (BD-WT, BD-Asp47Tyr, BD-Ser73Leu, BD-Phe83Ser, BD-
Val130Asp or BD-Gln131Stop). (B) wild-type and mutant AD-SEDLINs or BD-SEDLIN and each of the transcription factors BD-MBP1, AD-PITX1, AD-SF1.
Yeast growth was monitored for 48 hrs after spotting and incubation at 30uC using either double drop out, DDO (Leu-Trp-), media as a control or
quaternary drop out, QDO (Leu-Trp-Ade-His-), media in which the growth is dependent on the physical interaction between BD-SEDLIN and AD-
transcription factors, or AD-SEDLIN and the BD-transcription factor. The wild-type SEDLIN interacts with wild-type SEDLIN and all of the mutant
SEDLIN proteins, consistent with the proposed model for the formation of homodimers. However, the MBP1, PITX1 and SF1 fusion proteins, which
interact with the wild-type SEDLIN, interacted only with the mutant Asp47Tyr SEDLIN, but not with the mutant Ser73Leu, Phe83Ser, Val130Asp and
Gln131Stop SEDLINs.
doi:10.1371/journal.pone.0010646.g007
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Subcellular localization studies
COS7 cells, were transfected using Lipofectamine Plus
(Invitrogen Corporation) with: full-length SEDLIN wild-type or
mutant constructs prepared in pCMV-HA (HA-SEDLIN); and
MBP1, PITX1 and SF1 prepared in pCMV-cMyc (cMyc-MBP1,
cMyc-PITX1 and cMyc-SF1, respectively) as previously described
[23]. Twenty hours post-transfection, cells were stained using anti-
HA (Covance Inc.) and anti-cMyc (Santa Cruz Biotechnology,
Inc.) primary antibodies and AlexaFluorH594 donkey anti-mouse
and AlexaFluorH488 donkey anti-rabbit (Molecular Probes)
secondary antibodies and visualised using a laser scanning confocal
microscope (Confocal System LSM 510 META, Carl Zeiss), as
previously described [25]. For Western blot analysis, cells were
lysed and fractionated into nuclear and cytoplasmic extracts, and
biotin-conjugated anti-HA (Vector Laboratories, Inc.) and anti-
cMyc (Santa Cruz Biotechnology, Inc.) antibodies were used to
detect the presence of SEDLIN, MBP1, PITX1 and SF1 proteins
in the cell fractions as previously described [26]. Antibodies
against Lamin A/C and a-Tubulin (Santa Cruz Biotechnology,
Inc.) were used to assess the quality of the subcellular fraction
preparations. Nuclear and cytoplasmic fractions (40 mg of total
protein) were also analysed by 12% continuous non-denaturing
PAGE in 16Tris/Glycine buffer, transferred onto nitrocellulose
membrane and hybridised with anti-cMyc antibody (Santa Cruz
Biotechnology, Inc.). Secondary antibodies, horseradish peroxi-
dase-conjugated donkey anti-goat (Santa Cruz Biotechnology,
Inc.) and goat anti-mouse (Bio-Rad), were used and detected using
an Enhanced Chemiluminescence (ECL) Kit (GE Healthcare).
Co-immunoprecipitation
COS7 cells were transiently co-transfected with full-length wild-
type or mutant HA-SEDLINs and cMyc-MBP1, cMyc-PITX1,
cMyc-SF1, cMyc-SEDLIN or cMyc vector alone using Lipofecta-
mine Plus (Invitrogen Corporation). After 48 hrs, cells were lysed
in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1%
NP-40, 0.1% SDS, 0.5% deoxycholate, 1 mM phenylmethylsul-
fonyl fluoride) supplemented with protease inhibitors (Complete
Mini, Roche), and briefly sonicated. Co-immunoprecipitation was
performed using anti-HA (1 mg, Abcam) or anti-cMyc antibodies
(1 mg, Santa Cruz Biotechnology, Inc.). Protein complexes were
captured with Protein G-Sepharose beads (GE Healthcare), eluted
with Laemmli sample buffer (Bio-Rad) containing 5% b-
mercaptoethanol and separated on a 15% discontinuous SDS-
PAGE, followed by immunoblotting with biotin-conjugated anti-
HA antibody (Vector Laboratories, Inc.) for the detection of HA-
SEDLIN, and with anti-cMyc antibody (Santa Cruz Biotechnol-
ogy, Inc.) for the detection of cMyc-MBP1, cMyc-PITX1, cMyc-
SF1, or cMyc-SEDLIN proteins. Horseradish peroxidase-conju-
gated donkey anti-goat (Santa Cruz Biotechnology, Inc.) and goat
anti-mouse (Bio-Rad), were used and detected using an Enhanced
Chemiluminescence (ECL) Kit (GE Healthcare).
Yeast two-hybrid assays
Yeast two-hybrid assays were performed as described previously
[23]. Briefly, the coding regions of SEDLIN, MBP1, PITX1 and
SF1 were cloned in-frame into the Gal4 activation domain
encoding plasmid, pGADT7 (AD-SEDLIN, AD-MBP1, AD-
PITX1 and AD-SF1), and into the Gal4 DNA-binding domain
encoding plasmid, pGBKT7 (BD-SEDLIN, BD-MBP1, BD-
PITX1 and BD-SF1). Mutant SEDLINs were also cloned in-
frame into pGADT7 and pGBKT7. AD-MBP1, BD-PITX1 and
BD-SF1 showed self-activation, whereas BD-MBP1, AD-PITX1
and AD-SF1 constructs did not self-activate, and thus these
constructs were used for the study. The pGBKT7-p53 and
pGADT7-Large T antigen plasmids were used as controls
(Clontech) [27]. Competent AH109 yeasts cells were transformed
sequentially with the appropriate wild-type and mutant SEDLIN
plasmid constructs and the MBP1, PITX1 and SF1 plasmid
constructs, using the LiAc/single-stranded DNA/polyethylene
glycol procedure, as described previously [23]. Expression of
SEDLIN, MBP1, PITX1 and SF1 fusion proteins were confirmed
in protein extracts prepared from each clone, by SDS-PAGE and
Western blot analysis, using anti-HA and anti-cMyc as described
above.
Computer modelling of SEDLIN structure
The three-dimensional structure of the mouse Sedlin has been
reported [2], and because the mouse and human SEDLINs are
97% identical, we modelled the position of the human SEDLIN
mutations on this framework. The Sedlin three-dimensional
structure is archived in the Protein Data Bank (PDB) with the
accession number 1H3Q [PDB] (available at www.rcsb.org/pdb/
cgi/explore.cgi?pdbId = 1H3Q) and was visualized using the
MacPyMOL programme (DeLano Scientific LLC).
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